Use of subcutaneous natalizumab in routine care - Final results of a non-interventional, observational study (SISTER) in Germany and Austria.

Gold R, Schmidt S, Deisenhammer F, Motte J, Richter N, Taipale K, Salmen H C, Bohland C, Kahrer R, Schirduan K

Ther Adv Neurol Disord. 2026; 19:17562864261485201. PMID: 42719433. Abstract